BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25053904)

  • 21. Pivotal role of micro-CT technology in setting up an optimized lung fibrosis mouse model for drug screening.
    Khalajzeyqami Z; Grandi A; Ferrini E; Ravanetti F; Leo L; Mambrini M; Giardino L; Villetti G; Stellari FF
    PLoS One; 2022; 17(6):e0270005. PubMed ID: 35704641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the effect of filtered ultrafine particulate matter on bleomycin-induced lung fibrosis in a rat model using computed tomography, histopathologic analysis, and RNA sequencing.
    Kim C; Jeong SH; Kim J; Kang JY; Nam YJ; Togloom A; Cha J; Lee KY; Lee CH; Park EK; Lee JH
    Sci Rep; 2021 Nov; 11(1):22672. PubMed ID: 34811439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative measurement of bleomycin-induced lung fibrosis in rabbits using sequential in vivo regional analysis and high-resolution computed tomography: correlation with pathologic findings.
    Nagatani Y; Nitta N; Otani H; Mukaisho K; Sonoda A; Nitta-Seko A; Takahashi M; Murata K
    Acad Radiol; 2011 Jun; 18(6):672-81. PubMed ID: 21393029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.
    Dackor RT; Cheng J; Voltz JW; Card JW; Ferguson CD; Garrett RC; Bradbury JA; DeGraff LM; Lih FB; Tomer KB; Flake GP; Travlos GS; Ramsey RW; Edin ML; Morgan DL; Zeldin DC
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L645-55. PubMed ID: 21856819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abrogation of bleomycin-induced lung fibrosis by nitric oxide synthase inhibitor, aminoguanidine in mice.
    Giri SN; Biring I; Nguyen T; Wang Q; Hyde DM
    Nitric Oxide; 2002 Sep; 7(2):109-18. PubMed ID: 12223180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of water-soluble C(60) fullerenes on pulmonary fibrosis induced by bleomycin in mice].
    Dong R; Liu M; Huang XX; Liu Z; Jiang DY; Xiao HJ; Dai HP
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(22):1740-1744. PubMed ID: 28606286
    [No Abstract]   [Full Text] [Related]  

  • 27. Grading Bleomycin-Induced Pulmonary Fibrosis in ex vivo Mouse Lungs Using Ultrasound Image Analysis.
    Zhou B; Shao J; Schaefbauer KJ; Egan AM; Carmona EM; Limper AH; Zhang X
    J Ultrasound Med; 2021 Apr; 40(4):763-770. PubMed ID: 32865263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of lung TRPV1/TRPA1 in a cough model of bleomycin-induced pulmonary fibrosis in Guinea pigs.
    Guo Y; Ying S; Zhao X; Liu J; Wang Y
    BMC Pulm Med; 2019 Feb; 19(1):27. PubMed ID: 30717786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A micro-computed tomography-based method for the measurement of pulmonary compliance in healthy and bleomycin-exposed mice.
    Shofer S; Badea C; Auerbach S; Schwartz DA; Johnson GA
    Exp Lung Res; 2007; 33(3-4):169-83. PubMed ID: 17558678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal assessment of bleomycin-induced lung fibrosis by Micro-CT correlates with histological evaluation in mice.
    Ruscitti F; Ravanetti F; Essers J; Ridwan Y; Belenkov S; Vos W; Ferreira F; KleinJan A; van Heijningen P; Van Holsbeke C; Cacchioli A; Villetti G; Stellari FF
    Multidiscip Respir Med; 2017; 12():8. PubMed ID: 28400960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern.
    Wells AU; Rubens MB; du Bois RM; Hansell DM
    AJR Am J Roentgenol; 1993 Dec; 161(6):1159-65. PubMed ID: 8249719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis.
    Inomata M; Kamio K; Azuma A; Matsuda K; Kokuho N; Miura Y; Hayashi H; Nei T; Fujita K; Saito Y; Gemma A
    Respir Res; 2014 Feb; 15(1):16. PubMed ID: 24507087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelial Colony-Forming Cells Do Not Participate to Fibrogenesis in a Bleomycin-Induced Pulmonary Fibrosis Model in Nude Mice.
    Blandinières A; Gille T; Sadoine J; Bièche I; Slimani L; Dizier B; Gaussem P; Chaussain C; Planes C; Dorfmüller P; Israël-Biet D; Smadja DM
    Stem Cell Rev Rep; 2018 Dec; 14(6):812-822. PubMed ID: 30267203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis.
    Organ L; Bacci B; Koumoundouros E; Barcham G; Milne M; Kimpton W; Samuel C; Snibson K
    BMC Pulm Med; 2015 Jul; 15():81. PubMed ID: 26227819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of a DNA-hsp65 vaccine on bleomycin-induced lung injury.
    Padua AI; Silva CL; Ramos SG; Faccioli LH; Martinez JA
    J Bras Pneumol; 2008 Nov; 34(11):891-9. PubMed ID: 19099094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Static and dynamic mechanics of the murine lung after intratracheal bleomycin.
    Manali ED; Moschos C; Triantafillidou C; Kotanidou A; Psallidas I; Karabela SP; Roussos C; Papiris S; Armaganidis A; Stathopoulos GT; Maniatis NA
    BMC Pulm Med; 2011 May; 11():33. PubMed ID: 21627835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice.
    Trivedi R; Redente EF; Thakur A; Riches DW; Kompella UB
    Nanotechnology; 2012 Dec; 23(50):505101. PubMed ID: 23186914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
    Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model.
    Comeglio P; Filippi S; Sarchielli E; Morelli A; Cellai I; Corno C; Pini A; Adorini L; Vannelli GB; Maggi M; Vignozzi L
    J Endocrinol Invest; 2019 Mar; 42(3):283-294. PubMed ID: 29923060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fully automated micro‑CT deep learning approach for precision preclinical investigation of lung fibrosis progression and response to therapy.
    Buccardi M; Ferrini E; Pennati F; Vincenzi E; Ledda RE; Grandi A; Buseghin D; Villetti G; Sverzellati N; Aliverti A; Stellari FF
    Respir Res; 2023 May; 24(1):126. PubMed ID: 37161569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.